Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For weight loss, the FDA approved Wegovy HD (semaglutide 7.2 mg weekly) in March 2026
Phase 2 data published in the New England Journal of Medicine demonstrated substantial weight reduction in some participants exceeding 20% of body weight over 48 weeks alongside improvements in cardiometabolic markers
Peptide loss : Can't salvage, need new vial
Never modify your semaglutide dosing schedule without explicit instructions and ongoing supervision from your medical team
US$ 22.40
US$ 27.11
US$ 28.58
US$ 28.32
